Feedback / Questions
piclidenoson (CF101) - Can-Fite
https://www.globenewswire.com/news-release/2026/09/08/3357631/0/en/can-fite-reports-q2-2026-financial-results-and-ongoing-clinical-progress-highlighting-longer-than-anticipated-overall-survival-in-ongoing-pivotal-phase-iii-liver-cancer-study.html
Sep 8, 2026
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next